Compare RGTI & BRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RGTI | BRKR |
|---|---|---|
| Founded | 2013 | 1960 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | Biotechnology: Laboratory Analytical Instruments |
| Sector | Technology | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.8B | 5.5B |
| IPO Year | N/A | 2000 |
| Metric | RGTI | BRKR |
|---|---|---|
| Price | $17.53 | $39.01 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 13 |
| Target Price | $33.50 | ★ $49.54 |
| AVG Volume (30 Days) | ★ 22.3M | 2.3M |
| Earning Date | 01-01-0001 | 05-04-2026 |
| Dividend Yield | N/A | ★ 0.51% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,895,600,000.00 |
| Revenue This Year | N/A | $5.75 |
| Revenue Next Year | $179.00 | $3.99 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $6.86 | $28.53 |
| 52 Week High | $58.15 | $56.22 |
| Indicator | RGTI | BRKR |
|---|---|---|
| Relative Strength Index (RSI) | 46.64 | 39.47 |
| Support Level | $14.17 | $35.70 |
| Resistance Level | $26.96 | $42.89 |
| Average True Range (ATR) | 1.17 | 1.80 |
| MACD | 0.43 | 0.29 |
| Stochastic Oscillator | 65.90 | 57.40 |
Rigetti Computing Inc is engaged in the business of full-stack quantum computing. The company offers full-stack quantum computing platform as a cloud service to a wide range of end-users, directly through its Rigetti QCS platform, and also through cloud service providers. Its proprietary quantum-classical infrastructure provides ultra-low latency integration with public and private clouds for high-performance practical quantum computing. The company has developed the industry's first multi-chip quantum processor for scalable quantum computing systems. Geographically, the company derives the majority of its revenue from the United States.
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.